NSC |
Compound |
Enrichment |
Correlation |
NSC 672868 |
Null |
0.0212053315848711 |
0.12922477 |
NSC 678106 |
Rhamnazin |
0.0212053315848711 |
0.32470991 |
NSC 679024 |
1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- |
0.0212053315848711 |
-0.2076927 |
NSC 686393 |
Null |
0.0212053315848711 |
0.18119731 |
NSC 686551 |
Null |
0.0212053315848711 |
0.010839358 |
NSC 701022 |
Null |
0.0212053315848711 |
0.10738635 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0212053315848711 |
0.33551244 |
NSC 719667 |
7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one |
0.0212053315848711 |
0.13048202 |
NSC 740357 |
Null |
0.0212053315848711 |
0.24682308 |
NSC 762901 |
trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide |
0.0212053315848711 |
-0.087788772 |